Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-17

Clinical Trial Update: Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating temozolomide for patients with primary brain tumors or brain metastases has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temodar (Temozolomide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Brain and Central Nervous System Tumors, Metastatic Cancer | Phase 1 | Status: COMPLETED